Endoscopic Transorbital Approach for Select Recurrent and Newly Diagnosed Anteromedial Temporal Lobe Gliomas.

Risk factors for postoperative malignant progression of lower-grade gliomas: a systematic review and meta-analysis.

Investigation of mismatch repair protein expression in glioma.

Revisiting pediatric HGGs and PNETs according to the WHO CNS5 criteria: A clinical and genomic retrospective analysis.

Oligodendrogliomas: findings after classifying the same cohort using pre- and post-World Health Organization (WHO) 2021 criteria.

In silico analysis reveals distinct changes in markers of epithelial to mesenchymal transition in glioma subtypes.

Low-Grade Glioma in the Differential Diagnosis of Limbic Encephalitis.

A Patient With Oligoastrocytoma of Suprasellar Cistern Combined With Infantile Uterus.

A dual-genotype IDH-mutant infiltrating glioma, a real oligoastrocytoma in cerebral hemisphere.

Oligoastrocytoma: The Vanishing Entity With True Dual Genotype, a Report, its Molecular Profiles and Review of Literature.

Congress of Neurological Surgeons systematic review and evidence-based guidelines for the role of chemotherapy in newly diagnosed WHO Grade II diffuse glioma in adults: update.

Geriatric grade 2 and 3 gliomas: A national cancer database analysis of demographics, treatment utilization, and survival.

Single-cell transcriptomic analysis identifies downregulated phosphodiesterase 8B as a novel oncogene in IDH-mutant glioma.

Rare dual-genotype IDH mutant glioma: Review of previously reported cases and two new cases of true "oligoastrocytoma".

Genetically Distinct Oligosarcoma Arising from Oligodendroglioma: Systematic Review & Illustrative Case Example.

Design, synthesis and anticancer evaluation of novel arylhydrazones of active methylene compounds.

Meningioma and glioma as the first collision brain tumour reported in small animals.

Genomic profiles of IDH-mutant gliomas: MYCN-amplified IDH-mutant astrocytoma had the worst prognosis.

Machine learning predicts histologic type and grade of canine gliomas based on MRI texture analysis.

Concurrent IDH1 and IDH2 mutations in glioblastoma: A case report.

Recombinant polio-rhinovirus immunotherapy for recurrent paediatric high-grade glioma: a phase 1b trial.

Value of quantitative apparent diffusion coefficients in differentiating low-grade gliomas from mixed neuronal-glial tumors.

Morphologically, genetically and spatially mixed astrocytoma and oligodendroglioma; chronological acquisition of 1p/19q codeletion and CDKN2A deletion: a case report.

Prevalence of seizures in brain tumor: A meta-analysis.

True anaplastic oligoastrocytoma with dual genotype: illustrative case.

Subtyping and grading of lower-grade gliomas using integrated feature selection and support vector machine.

Malignant oligoastrocytoma in the spinal cord of a cat.

Clinical Profile, Pathology, and Molecular Typing of Gliomas with Oligodendroglial Morphology: A Single Institutional Experience.

Synergistic anti-tumor efficacy of mutant isocitrate dehydrogenase 1 inhibitor SYC-435 with standard therapy in patient-derived xenograft mouse models of glioma.

FISH analyses for 1p and 19q status on gliomas: Reporting an 8 years' experience from a tertiary care center in the Middle East.

Disparities in Reported Testing for 1p/19q Codeletion in Oligodendroglioma and Oligoastrocytoma Patients: An Analysis of the National Cancer Database.

Clinical and histopathological profile of dysembryoplastic neuroepithelial tumor: An experience from a tertiary care center.

Rapid Spectroscopic Liquid Biopsy for the Universal Detection of Brain Tumours.

Palliative endoscopic third ventriculostomy for pediatric primary brain tumors: a single-institution case series.

Upfront Therapy of Aggressive/High-Risk Low-Grade Glioma: Single-Institution Outcome Analysis of Temozolomide-Based Radio-Chemotherapy and Adjuvant Chemotherapy.

High IER5 Gene Expression Is Associated With Poor Prognosis in Glioma Patients.

Incremental Utility of Tc-99m Glucohepatonate Single-Photon Emission Computed Tomography over 18F-Flourodeoxyglucose Positron Emission Tomography in Diagnosis of Brain Tumor Recurrence - Old is Gold.

Prognostic Role of EYA4 in Lower Grade Glioma with IDH1 Mutation and 1p19q Co-Deletion.

[Diffuse Astrocytoma with Malignant Progression after Long-term Temozolomide Monotherapy:A Case Report].

Anaplastic oligoastrocytoma with dual genotype: A case report of a rare entity.

Risk Stratification in Low Grade Glioma: A Single Institutional Experience.

Incidence of Gliomas in Municipalities of Zenica - Doboj Canton in Bosnia and Herzegovina - A 10-Year Study.

A dual-genotype oligoastrocytoma with histologic, molecular, radiological and time-course features.

Surgical treatment of low-grade brain tumors associated with epilepsy.

Nuclear H3 K27me3 is retained in both components of dual genotype oligoastrocytoma.

Phase I clinical trial of temsirolimus and perifosine for recurrent glioblastoma.

Low expression of FOSL1 is associated with favorable prognosis and sensitivity to radiation/pharmaceutical therapy in lower grade glioma.

Pediatric Kidney Transplantation in Perú: A Single-Center Initial Experience.

Early versus delayed postoperative radiotherapy for treatment of low-grade gliomas.

Acute and chronic hemorrhage from radiation-induced cavernous malformation associated with late-delayed radiation necrosis in long surviving glioma patients: A case report.

Engrailed 1 overexpression as a potential prognostic marker in Lower Grade Glioma.

Recurrent Glioma With Lineage Conversion From Oligodendroglioma to Astrocytoma in Two Cases.

The crystal structure of Capicua HMG-box domain complexed with the ETV5-DNA and its implications for Capicua-mediated cancers.

Brain cancer survival in Canada 1996-2008: effects of sociodemographic characteristics.

The pan-cancer mutational landscape of the PPAR pathway reveals universal patterns of dysregulated metabolism and interactions with tumor immunity and hypoxia.

Clinical importance of molecular markers of adult diffuse glioma.

Phase I-II trial of imatinib mesylate (Gleevec; STI571) in treatment of recurrent oligodendroglioma and mixed oligoastrocytoma. North central cancer treatment group study N0272 (ALLIANCE/NCCTG).

von Willebrand Factor Gene Expression in Primary Lower Grade Glioma: Mutually Co-Occurring Mutations in von Willebrand Factor, ATRX, and TP53.

Incidence trends of adult malignant brain tumors in Finland, 1990-2016.

A Pilot Study of Vaccine Therapy with Multiple Glioma Oncoantigen/Glioma Angiogenesis-Associated Antigen Peptides for Patients with Recurrent/Progressive High-Grade Glioma.

Neurosurgical Therapy for Status Epilepticus in Oligoastrocytoma Patients.

Oligo-astrocytoma in LZTR1-related Noonan syndrome.

Allergy may confer better survival on patients with gliomas.

Sequencing of Chemotherapy and Radiotherapy for Newly Diagnosed Anaplastic Oligodendroglioma and Oligoastrocytoma.

The Applicability of Haarlem Integrated Diagnostic System in Diffuse Glial Tumors and Molecular Methods Affecting Prognosis.

Molecular features and clinical outcomes in surgically treated low-grade diffuse gliomas in patients over the age of 60.

Successful treatment of a BRAF V600E-mutant extracranial metastatic anaplastic oligoastrocytoma with vemurafenib and everolimus.

Increased HSPG2 expression independently predicts poor survival in patients with oligoastrocytoma and oligodendroglioma.

Comparison of Radiation Therapy Alone and Chemotherapy Alone for Low-Grade Gliomas without Surgical Resection.

Possibility of venoarterial extracorporeal membranous oxygenator being a bridging therapy for hemodynamic deterioration of pulmonary tumor thrombotic microangiopathy prior to initiating chemotherapy: A case report.

Extracranial metastasis of anaplastic oligoastrocytoma.

Impact of adjuvant treatments on survival in Korean patients with WHO grade II gliomas: KNOG 15-02 and KROG 16-04 intergroup study.

Association of MGMT Promoter Methylation Status With Survival Outcomes in Patients With High-Risk Glioma Treated With Radiotherapy and Temozolomide: An Analysis From the NRG Oncology/RTOG 0424 Trial.

Age and surgical outcome of low-grade glioma in Sweden.

Symptomatic Remote Cyst after BCNU Wafer Implantation for Malignant Glioma.

Multi-institutional study of treatment patterns in Korean patients with WHO grade II gliomas: KNOG 15-02 and KROG 16-04 intergroup study.

Diffuse low-grade glioma mimicking ischaemic infarct: a case report.

Clinical importance of eflornithine (α-difluoromethylornithine) for the treatment of malignant gliomas.

The 2016 revision of the WHO Classification of Central Nervous System Tumours: retrospective application to a cohort of diffuse gliomas.

Prognostic markers for survival in patients with oligodendroglial tumors; a single-institution review of 214 cases.

SEOM clinical guideline of diagnosis and management of low-grade glioma (2017).

SEOM clinical guidelines for anaplastic gliomas (2017).

Spinal metastases of two different grade oligodendrogliomas: a case report and review of literature.

2016 Updates to the WHO Brain Tumor Classification System: What the Radiologist Needs to Know.

Intraoperative Squash and Touch Preparation Cytology of Brain Lesions Stained with H+E and Diff-Quik™: A 20-Year Retrospective Analysis and Comparative Literature Review.

Reclassification of Mixed Oligoastrocytic Tumors Using a Genetically Integrated Diagnostic Approach.

Prognostic relevance of NG2/CSPG4, CD44 and Ki-67 in patients with glioblastoma.

Threshold of the extent of resection for WHO Grade III gliomas: retrospective volumetric analysis of 122 cases using intraoperative MRI.

WHO 2016 Classification of gliomas.

A simple algorithmic approach using histology and immunohistochemistry for the current classification of adult diffuse glioma in a resource-limited set-up.

Extracranial metastasis of anaplastic oligoastrocytoma: a case report and review of the literature.

Rates of Seizure Freedom After Surgical Resection of Diffuse Low-Grade Gliomas.

Extent of resection and timing of surgery in adult low grade glioma.

Multifocal and multicentric low-grade oligoastrocytoma in a young patient.

Treatment Outcomes in 1p19q Co-deleted/Partially Deleted Gliomas.

Multicenter phase II study of temozolomide and myeloablative chemotherapy with autologous stem cell transplant for newly diagnosed anaplastic oligodendroglioma.

Mapping an Extended Neurochemical Profile at 3 and 7 T Using Accelerated High-Resolution Proton Magnetic Resonance Spectroscopic Imaging.

Patterns of care and treatment outcomes in older adults with low grade glioma: a 50-year experience.

Dual-Genotype Diffuse Low-Grade Glioma: Is It Really Time to Abandon Oligoastrocytoma As a Distinct Entity?

Clinical predictors for survival and treatment outcome of high-grade glioma in Prasat Neurological Institute.

Outcomes for Anaplastic Glioma Treated With Radiation Therapy With or Without Concurrent Temozolomide.

The usefulness of 18F-fluorocholine PET/CT in the detection of recurrence of central nervous system primary neoplasms.

Feline glioma: a retrospective study and review of the literature.

The impact of body mass index and height on the risk for glioblastoma and other glioma subgroups: a large prospective cohort study.

Focal seizure induced by preoperative navigated transcranial magnetic stimulation in a patient with anaplastic oligoastrocytoma.

Treatment Strategies for Low-Grade Glioma in Adults.

Neurosurgery concepts: Key perspectives on intrathecal fluorescein for detecting intraoperative cerebrospinal fluid leak during endoscopic endonasal surgery, spinal intraarterial chemotherapy, oligoastrocytoma classification by in situ molecular genetics, and prenatal myelomeningocele closure and the need for cerebrospinal fluid shunt placement.

Diagnostic revision of 206 adult gliomas (including 40 oligoastrocytomas) based on ATRX, IDH1/2 and 1p/19q status.

Personalized anticancer therapy selection using molecular landscape topology and thermodynamics.

Temozolomide low-dose chemotherapy in newly diagnosed low-grade gliomas: activity, safety, and long-term follow-up.

Stereotactic brachytherapy using iodine 125 seeds for the treatment of primary and recurrent anaplastic glioma WHO° III.

Molecular and histologic characteristics of pseudoprogression in diffuse gliomas.

Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study.

Health-related quality of life in patients with high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study.

Unique case of oligoastrocytoma with recurrence and grade progression: Exhibiting differential expression of high mobility group-A1 and human telomerase reverse transcriptase.

Intraoperative Probe-Based Confocal Laser Endomicroscopy in Surgery and Stereotactic Biopsy of Low-Grade and High-Grade Gliomas: A Feasibility Study in Humans.

Genotyping low-grade gliomas among Hispanics.

Symptom resolution in infiltrating WHO grade II-IV glioma patients undergoing surgical resection.

A case of medulloblastoma in adult patient affected by anaplastic oligoastrocytoma.

Development of a transplantable glioma tumour model from genetically engineered mice: MRI/MRS/MRSI characterisation.

Impact of histopathological transformation and overall survival in patients with progressive anaplastic glioma.

IDH1 Mutation in Gliomas in Mosul City - Iraq.

High-grade glioma with anterior skull base erosion and intranasal extension: case report.

Anaplastic astrocytoma and non-1p/19q co-deleted anaplastic oligoastrocytoma: long-term survival, employment, and performance status of survivors.

Pre-operative Embolization of Intracranial and Extracranial Tumors: A Review of 37 Cases.

Epidermal Growth Factor Receptor and Ki-67 Expression in Canine Gliomas.

[Glioneuronal tumor with neuropil-like island: report of four cases and review of literature].

Primary Spinal Oligoastrocytoma.

Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma.

18F-fluoroethyl-L-tyrosine positron emission tomography for the differential diagnosis of tumefactive multiple sclerosis versus glioma: A case report.

Overview of Transgenic Glioblastoma and Oligoastrocytoma CNS Models and Their Utility in Drug Discovery.

Low-grade and anaplastic oligodendroglioma.

Detection of ATRX and IDH1-R132H immunohistochemistry in the progression of 211 paired gliomas.

A rare case of oligoastrocytoma with atypical symptoms initially diagnosed as multiple sclerosis: A case report.

Primary spinal cord anaplastic oligoastrocytoma presenting with paraplegia.

Presence of neural progenitors in spontaneous canine gliomas: A histopathological and immunohistochemical study of 20 cases.

Clinicopathological factors predictive of postoperative seizures in patients with gliomas.

Epidermal growth factor receptor (EGFR) gene amplification in high-grade gliomas: Western Indian tertiary cancer center experience.

Prognostic significance of histomolecular subgroups of adult anaplastic (WHO Grade III) gliomas: applying the 'integrated' diagnosis approach.

The effect of pregnancy on survival in a low-grade glioma cohort.

A case of osteoclast-like giant cell-rich epithelioid glioblastoma with BRAF V600E mutation.

Primary spinal oligoastrocytoma mimicking longitudinally extensive transverse myelitis.

Oligodendrogliomas: a short history of clinical developments.

Procarbazine, lomustine and vincristine or temozolomide: which is the better regimen?

The role of surgery in the management of patients with diffuse low grade glioma: A systematic review and evidence-based clinical practice guideline.

Management of patients with recurrence of diffuse low grade glioma: A systematic review and evidence-based clinical practice guideline.

The role of initial chemotherapy for the treatment of adults with diffuse low grade glioma : A systematic review and evidence-based clinical practice guideline.

Genetics and imaging of oligodendroglial tumors.

The role of surgery in grade II/III oligodendroglial tumors.

Does morphological assessment have a role in classifying oligoastrocytoma as 'oligodendroglial' versus 'astrocytic'?

Correlation of diffusion tensor and dynamic susceptibility contrast MRI with DNA ploidy and cell cycle analysis of gliomas.

Survival of adults with primary malignant brain tumours in Europe; Results of the EUROCARE-5 study.

PC or PCV, That Is the Question: Primary Anaplastic Oligodendroglial Tumors Treated with Procarbazine and CCNU With and Without Vincristine.

A multicenter study of anaplastic oligodendroglioma: the Korean Radiation Oncology Group Study 13-12.

Solitary "aggressive" leptomeningeal anaplastic oligoastrocytoma.

Stereotactic interstitial brachytherapy for the treatment of oligodendroglial brain tumors.

Genetic and epigenetic characterization of low-grade gliomas reveals frequent methylation of the MLH3 gene.

Combined IDH1 mutation and MGMT methylation status on long-term survival of patients with cerebral low-grade glioma.

Dendritic cell-based immunotherapy targeting Wilms' tumor 1 in patients with recurrent malignant glioma.

Biopsy Proven Tumefactive Multiple Sclerosis with Concomitant Glioma: Case Report and Review of the Literature.

IDH mutation, 1p19q codeletion and ATRX loss in WHO grade II gliomas.

Hypomethylated Rab27b is a progression-associated prognostic biomarker of glioma regulating MMP-9 to promote invasion.

Quantitative fluorescence using 5-aminolevulinic acid-induced protoporphyrin IX biomarker as a surgical adjunct in low-grade glioma surgery.

Application of technical strategies for surgical management of adult intrinsic pontine gliomas: a retrospective series.

IDH1 and IDH2 mutations in different histologic subtypes and WHO grading gliomas in a sample from Northern Brazil.

Phase II trial of pre-irradiation and concurrent temozolomide in patients with newly diagnosed anaplastic oligodendrogliomas and mixed anaplastic oligoastrocytomas: long term results of RTOG BR0131.

Impending Impact of Molecular Pathology on Classifying Adult Diffuse Gliomas.

Combined ATRX/IDH1 immunohistochemistry predicts genotype of oligoastrocytomas.

Immunohistochemical profiles of IDH1, MGMT and P53: practical significance for prognostication of patients with diffuse gliomas.

Oligodendroglioma: pathology, molecular mechanisms and markers.

Anaplastic glioma: current treatment and management.

Radiotherapy and temozolomide for anaplastic astrocytic gliomas.

Opsoclonus-myoclonus syndrome in a patient with an anaplastic oligoastrocytoma.

Prognostic value of volume-based measurements on (11)C-methionine PET in glioma patients.

Dynamic study of methionine positron emission tomography in patients with glioblastoma with oligodendroglial components.

Bevacizumab and irinotecan in recurrent malignant glioma, a single institution experience.

Semiological and electroencephalographic features of epilepsy with amygdalar lesion.

Astroblastoma: beside being a tumor entity, an occasional phenotype of astrocytic gliomas?

Health-related quality of life in stable, long-term survivors of low-grade glioma.

Possible induction of multiple seizure foci due to parietal tumour and anti-NMDAR antibody.

Impact of 1p/19q codeletion and histology on outcomes of anaplastic gliomas treated with radiation therapy and temozolomide.

The impact of adjuvant radiation therapy for high-grade gliomas by histology in the United States population.

Anaplastic oligoastrocytoma: is molecular stratification based on 1p/19q status alone appropriate?